IFRS 17 CSM Roll-Forward: Calculating and Disclosing the Contractual Service Margin

IFRS 17 and the CSM: What Actuaries Need to Know

IFRS 17 Insurance Contracts (effective January 1, 2023) fundamentally changed how insurers report profit. Under the old IFRS 4, insurers could recognize profit at policy inception — building conservative reserves and releasing them opportunistically. Under IFRS 17, the Contractual Service Margin eliminates day-one profit recognition and forces unearned profit onto the balance sheet, to be released systematically as coverage is provided. For actuaries at life insurers and annuity writers, the CSM roll-forward table is now the central schedule explaining how profit moves from balance sheet to income statement each quarter.

The CSM is actuarially intensive: initial recognition requires a best estimate of future cash flows, discounting at insurance contract discount rates (not just one rate — a yield curve), and a risk adjustment calculated at the 75th percentile confidence level (or equivalent). Each quarter, the CSM is unlocked for experience versus assumptions, financial adjustments, and new business. For a life insurer with $2 billion in policies, the CSM disclosure note alone can run 8-12 lines of the roll-forward, each requiring actuarial sign-off.

ClaudeFinanceLab's Insurance & Actuarial templates include IFRS 17 CSM Roll-Forward Assistant and IFRS 17 Disclosure Drafter, designed for actuaries who know the standard and need to automate the narrative and calculation-checking workflow.

Initial Recognition: Setting the Opening CSM

At initial recognition of a group of insurance contracts, the CSM is set to ensure no day-one gain on profitable groups. The calculation: FCF (Fulfillment Cash Flows = present value of expected future cash flows + risk adjustment). If FCF is negative (liability), CSM = -FCF. If FCF is positive (onerous), the group is recognized as an onerous contract immediately in P&L — there is no CSM for onerous groups.

• "IFRS 17 initial recognition calculation for a life insurance group: New business cohort (Q4 2026): 840 whole life policies, sum insured average $185,000. Expected future cash outflows (PV at locked-in discount rate 4.8%): death benefits $48.2M, maturity benefits $12.4M, expenses $8.1M, total PV outflows $68.7M. Expected future premiums (PV): $72.3M. Risk adjustment: $3.8M (75th percentile confidence interval, additive to liability). Calculate: (1) fulfillment cash flows (FCF) = PV outflows + risk adjustment - PV premiums, (2) is the group onerous or profitable?, (3) opening CSM at initial recognition, (4) how does day-one P&L compare to IFRS 4 treatment if we had recognized a day-one profit?"
• "Opening CSM calculation for an annuity group: 420 immediate annuity contracts issued in Q3 2026. Total single premium received: $68.4M. Expected annuity payments (PV at locked-in rate 5.1%): $61.2M (using latest mortality tables with 0.8% annual improvement). Risk adjustment: $2.9M. Acquisition cash flows (commissions paid): $1.4M — these are eligible cash flows under IFRS 17.28(a). Calculate: (1) FCF at initial recognition, (2) opening CSM — note: single premiums are already received so the timing difference is important, (3) what is the coverage unit pattern for the annuity group if 40% of policyholders are expected to survive to age 90+?"

The CSM Roll-Forward: Quarter by Quarter

The IFRS 17.105(c) disclosure requires a reconciliation of the opening and closing CSM. The standard movements are: opening CSM + new business CSM + interest accretion + unlocking (changes in estimates re future service) - CSM release (amortization) +/- FX translation = closing CSM. Understanding what goes into each line — and whether it flows through CSM or directly to P&L — is the central actuarial judgment in IFRS 17 reporting.

• "IFRS 17 CSM roll-forward for Q3 2026: Opening CSM: $142.8M. New business added during quarter: 380 policies with opening CSM of $8.4M. Interest accretion at locked-in rate 4.8%: calculate for the quarter (hint: 4.8% annual = 1.175% quarterly, applied to opening balance + approximate mid-quarter new business). Experience adjustments related to future service (unlocking): mortality experience better than expected — PV of reduced future claims = $2.1M favorable (increases CSM). Lapse experience worse than expected — PV impact on future cash flows = $1.4M adverse (reduces CSM). Revised expense loading — actuarial team increased expense loadings for future periods by $0.9M (reduces CSM). CSM amortization: Q3 coverage units 8,200 out of remaining lifetime coverage units 142,000 = 5.77% of remaining CSM released. FX: no FX impact (all GBP). Show the complete Q3 roll-forward table."
• "Distinguish CSM vs P&L adjustments: For each of the following experience items in Q3, state whether it adjusts the CSM or goes directly to insurance service result: (1) Actual claims $4.8M vs expected $4.2M — $600K adverse claims experience, (2) actual lapses 2.4% vs expected 1.8% — affects both current period (reduced premiums received) and future service expectations, (3) actual operating expenses $890K vs expected $820K — $70K adverse, (4) revised mortality improvement assumption — PV of future benefit cash flow change $3.2M favorable, (5) investment returns on underlying items exceed expected by $1.1M (this is a unit-linked product using VFA), (6) risk adjustment release for risk expired in Q3: $340K. Classify each item and explain the reasoning under IFRS 17."

The Locked-In Rate vs. Current Discount Rate: Separating Finance Income

Under IFRS 17, financial income or expense arises because the discount rate used to measure the insurance contract liability can be split: the CSM and insurance revenue use the locked-in rate (at contract inception), while the full liability measurement uses current rates. The difference — the unwinding at current rates vs. locked-in rates — creates an insurance finance income or expense (IFIE) component. Entities can choose (as an accounting policy) to disaggregate IFIE: recognize the locked-in rate effect in profit or loss and the remainder in OCI (Other Comprehensive Income). This choice matters enormously for P&L volatility.

• "IFRS 17 insurance finance income — OCI vs P&L: Our group of annuity contracts: Carrying amount of FCF at period start: $284.7M (liability). Locked-in rate at inception: 4.2%. Current rate at period end: 5.8%. Unwinding at current rate: 5.8% annual / 4 = 1.45% × $284.7M = $4.1M. Unwinding at locked-in rate: 4.2% annual / 4 = 1.05% × $284.7M = $3.0M. We have elected to disaggregate IFIE with the difference in OCI. Show: (1) P&L insurance finance income (at locked-in rate), (2) OCI amount (difference attributable to rate change from 4.2% to 5.8%), (3) how this election reduces P&L volatility in rising rate environments, (4) if rates fall back to 4.8% by year end, what happens to the accumulated OCI balance?"
• "Variable Fee Approach (VFA) CSM roll-forward: We have a unit-linked endowment product group. Opening CSM: $38.4M. Underlying items (unit-linked investment fund): fair value increased by $4.2M in the quarter (6% annualized return on $280M of underlying assets). The entity fee is 1.5% of fund value annually. VFA-specific rules: changes in value of underlying items adjust the CSM, not P&L. Fee income earned in the quarter: 1.5% / 4 = $1.05M (this is insurance revenue). Risk adjustment release: $180K. Show the VFA CSM roll-forward for Q3 and explain why the $4.2M underlying item movement does not affect P&L under VFA."

Coverage Units and Amortization Methodology

The CSM amortization pattern depends on the coverage unit definition — and different products require different approaches. For term life: coverage units are usually sum at risk (SAR), which decline if policy reserves build up relative to the sum insured. For annuities: expected number of payments remaining (or expected number of annuity payments over the group's lifetime). For health insurance: coverage period duration if benefits are constant. For participating life insurance under VFA: number of investment-return-generating periods. IFRS 17.B119-B119B provides the guidance but leaves significant judgment to the actuary.

• "Coverage unit analysis for a term life insurance group: 1,200 10-year level term policies issued in 2022, sum insured $250,000 each. As of Q4 2026 (4 years into coverage): 1,110 policies in-force (90 lapsed). Expected future lapse rates: 8% per year for years 5-10. Mortality: age-dependent, average 0.18% per year for the remaining cohort. Coverage units used: Sum at Risk approach — SAR = max(death benefit - reserve, 0). Current average reserve per policy: $2,800. Calculate: (1) coverage units provided in Q4 2026, (2) expected remaining lifetime coverage units as at Q4 2026 (show year-by-year projection), (3) amortization % for Q4 2026, (4) how does SAR coverage unit compare to 'sum insured' approach — when does the difference matter most?"
• "Onerous contract assessment: Our group of 5-year savings endowments is showing signs of becoming onerous. Opening FCF (liability): $8.4M, opening CSM: $12.1M. Q3 experience: expected surrender value payable on lapses has increased because a market rate increase made our product's guaranteed crediting rate of 3.5% uncompetitive — surrender values in Q3 were $2.1M above expected. For future service, we now expect additional surrenders reducing future premium income PV by $4.8M and increasing future surrender costs by $3.2M. Is this group still profitable? Show: (1) the unlocking calculation — does the adverse change reduce CSM to zero and require P&L recognition of the onerous excess?, (2) what disclosure is required under IFRS 17 for an onerous group?"

IFRS 17 Disclosure Note: The CSM Roll-Forward Table

IFRS 17 Paragraph 101 requires extensive disclosures reconciling the opening and closing insurance contract liability. Paragraph 105 specifies the CSM roll-forward as a required component. The note must separately show the BBA, PAA, and VFA components if applicable. Many insurers find this disclosure the most actuarially intensive part of IFRS 17 implementation — each line requires actuarial methodology documentation and cross-checking against the underlying calculation systems.

• "Draft IFRS 17 Note 24 — Insurance Contract Liabilities: CSM Roll-Forward section: Our life insurance business has two product groups: whole life (BBA) and unit-linked (VFA). BBA whole life Q3 roll-forward: Opening CSM $142.8M; New business $8.4M; Interest accretion (4.8% locked-in) $1.7M; Changes in estimates re future service (unlocking): mortality improvement $2.1M favorable, lapse revision ($1.4M) adverse, expense revision ($0.9M) adverse — net ($0.2M); CSM release to revenue ($8.7M); FX nil; Closing CSM $144.0M. VFA unit-linked Q3 roll-forward: Opening CSM $38.4M; New business $1.2M; Interest accretion (locked-in) $0.4M; Change in entity's share of fair value of underlying items: $4.2M; CSM release ($1.1M); Closing CSM $43.1M. Draft the IFRS 17 paragraph 105 compliant disclosure note table for both groups, including the required line items and a brief methodology note."
• "IFRS 17 Paragraph 125 sensitivity disclosure: Our annuity portfolio FCF is sensitive to discount rates and mortality. Provide a sensitivity disclosure: (1) if the discount rate rises 100bps, FCF impact and CSM impact (note: under BBA with OCI election, rate change goes to OCI not P&L), (2) if mortality improves 5% faster than assumed (longevity risk), PV impact on future annuity payments: increase of $18.4M — does this change go to CSM or P&L? (3) if expense inflation is 2% above assumed annually, PV impact on future expenses: $3.2M increase — CSM or P&L? Draft the sensitivity table and narrative required under IFRS 17 paragraph 125 disclosures."

Where to Start

For actuaries implementing IFRS 17 CSM calculations for the first time, start with a single, simple product group — ideally a term life or group risk product where the coverage unit definition is straightforward and the CSM movements are driven primarily by mortality and lapse experience. Build the roll-forward for one quarter manually with Claude checking your logic at each step. Once you have confidence in the mechanics, extend to participating and unit-linked products where the VFA rules add complexity. The ClaudeFinanceLab Insurance & Actuarial templates include IFRS 17 CSM Roll-Forward Assistant (covering all three approaches) and IFRS 17 Disclosure Drafter for generating the Note 24 disclosure text. See also Life Insurance Reserving with Claude AI and IBNR Reserve Calculation for P&C.

Frequently Asked Questions

Can a CSM balance become negative?

No — a negative CSM is not permitted under IFRS 17. If adverse experience or revised assumptions reduce the CSM to zero, any remaining excess is recognized immediately in profit or loss as an insurance service expense (the group is onerous from that point forward). The CSM floor at zero is a fundamental feature of the standard: the CSM represents unearned profit, and once the profit is fully consumed, any further losses must be recognized immediately rather than deferred. An insurer with a large positive CSM has a "hidden asset" of future profit locked on its balance sheet; a CSM of zero on a product line is an early warning of margin compression.

What is the difference between the risk adjustment and the CSM?

Both are components of the IFRS 17 liability, but they represent different things. The risk adjustment (RA) is the compensation the insurer requires for bearing the uncertainty in non-financial risks (mortality, morbidity, lapse — not interest rate or market risk). It is calculated at a confidence level chosen by the entity (most use 75th percentile equivalent) and is released to profit as risk is resolved. The RA release is the amount charged to revenue each period for risk expiry. The CSM, by contrast, represents the expected profit (not a risk charge) — the CSM is earned as services are delivered, while the RA is earned as uncertainty is resolved. Confusingly, changes in the RA related to future service adjust the CSM (not P&L directly), while changes in RA related to current or past service go directly to profit.

How does IFRS 17 affect ROE for life insurers compared to IFRS 4?

IFRS 17 typically reduces reported ROE in the first years of adoption and then smooths it over time. Under IFRS 4, a profitable life insurer could recognize conservative reserves and release them as "reserve releases" that boosted profit in good years. Under IFRS 17, that day-one profit is locked in the CSM and released systematically — there are no sudden reserve releases to inflate ROE. The flip side: ROE under IFRS 17 is more predictable and less susceptible to management through reserve assumptions. Investors and rating agencies generally view IFRS 17 ROE as more comparable across insurers. However, the transition creates one-time CSM establishment charges for long-tail products that some insurers have found significant.

Is the CSM concept the same under US GAAP (LDTI) as under IFRS 17?

Not exactly. ASC 944 Long-Duration Targeted Improvements (LDTI, effective 2023 for large filers) has a similar concept called the Deferred Profit Liability (DPL) for limited-payment contracts (where premiums are paid over a shorter period than coverage — e.g., single premium or short-pay whole life). The DPL is analogous to the CSM. However, LDTI does not require a CSM-equivalent for all long-duration contracts — instead, LDTI focuses on unlocking the net premium ratio and updating discount rates each period. For GAAP-reporting US life insurers, the DPL/LDTI framework and IFRS 17 CSM are conceptually related but have meaningful technical differences in scope, discount rate methodology, and P&L presentation.